New Targets in the Treatment of Metastatic Prostate Cancer

September 08, 2024

Videos

Beyond Androgen Blockade – New Pathways and Novel Treatments in mHSPC and mCRPC

The Biological Basis of Metastatic Prostate Cancer – The Unmet Medical Need for New Targets and Novel Treatment Pathways

Daniel George, MD

VIEW VIDEO

PSMA PET as a Biomarker for Advanced Prostate Cancer

A. Oliver Sartor, MD

VIEW VIDEO

Unlocking the Future of mCRPC Treatment: Exploring Immune Checkpoint Inhibitors for MMR Loss and MSI-High

Sumit K. Subudhi, MD, PhD

VIEW VIDEO

AKT Inhibitors – Targeting PI3K/AKT/MTOR Signaling Axis

Cora N. Sternberg, MD, FACP

VIEW VIDEO

Broadening Treatment Horizons with CDK4/6 Inhibitors from Breast to Prostate Cancer

Rana McKay, MD

VIEW VIDEO

CONNECT WITH US

Questions or Comments? Email us at

Digital Science Press, LLC
2011 Phaethon Lane
Reno, NV 89523

You are receiving this email because you have chosen to receive emails from UroToday.